OBJECTIVE: The objective of this study was to investigate factors that may influence the interval between symptom onset and JSLE diagnosis. METHODS: Data from all patients recruited to the UK JSLE Cohort Study between 2006 and 2011 and meeting ACR criteria for lupus were analysed. Variables associated with time between symptom onset and diagnosis were identified using correlation tests. Linear regression was used to identify independent predictors of access to care. RESULTS: Two hundred and fifty-seven children with JSLE were included in the analysis (216 females, 41 males, ratio 5.3:1). The median time from symptom onset to diagnosis was 0.4 years (range 0.0-14.1 years, interquartile range 0.2-1.4). A linear regression model identified being of African or Caribbean origin (P = 0.006), Asian (P = 0.045), referred by a paediatrician (P = 0.047) or having nephritis (P = 0.045) at presentation as independent predictors of shorter time to diagnosis. Being of Caribbean or Asian origin, compared with white, was associated with a 56% and 37% reduction in geometric mean time to diagnosis, respectively. Similarly, being referred to paediatric rheumatology by a paediatrician or having nephritis at presentation was also associated with a 32% and 36% reduction in geometric mean time to diagnosis, respectively. CONCLUSION: Within this national UK cohort, ethnic origin, initial source of referral and having lupus nephritis at presentation were strong predictors of the interval to establishing a diagnosis of JSLE.
OBJECTIVE: The objective of this study was to investigate factors that may influence the interval between symptom onset and JSLE diagnosis. METHODS: Data from all patients recruited to the UK JSLE Cohort Study between 2006 and 2011 and meeting ACR criteria for lupus were analysed. Variables associated with time between symptom onset and diagnosis were identified using correlation tests. Linear regression was used to identify independent predictors of access to care. RESULTS: Two hundred and fifty-seven children with JSLE were included in the analysis (216 females, 41 males, ratio 5.3:1). The median time from symptom onset to diagnosis was 0.4 years (range 0.0-14.1 years, interquartile range 0.2-1.4). A linear regression model identified being of African or Caribbean origin (P = 0.006), Asian (P = 0.045), referred by a paediatrician (P = 0.047) or having nephritis (P = 0.045) at presentation as independent predictors of shorter time to diagnosis. Being of Caribbean or Asian origin, compared with white, was associated with a 56% and 37% reduction in geometric mean time to diagnosis, respectively. Similarly, being referred to paediatric rheumatology by a paediatrician or having nephritis at presentation was also associated with a 32% and 36% reduction in geometric mean time to diagnosis, respectively. CONCLUSION: Within this national UK cohort, ethnic origin, initial source of referral and having lupus nephritis at presentation were strong predictors of the interval to establishing a diagnosis of JSLE.
Authors: Tamar B Rubinstein; Wenzhu B Mowrey; Norman T Ilowite; Dawn M Wahezi Journal: Arthritis Care Res (Hoboken) Date: 2018-02-07 Impact factor: 4.794
Authors: Nicola Smith; Victoria Mercer; Jill Firth; Sharmila Jandial; Katharine Kinsey; Helen Light; Alan Nye; Tim Rapley; Helen E Foster Journal: Rheumatol Adv Pract Date: 2020-10-16
Authors: Laura B Lewandowski; Melissa H Watt; Laura E Schanberg; Nathan M Thielman; Christiaan Scott Journal: Pediatr Rheumatol Online J Date: 2017-02-23 Impact factor: 3.054
Authors: Helen E Foster; Christiaan Scott; Carl J Tiderius; Matthew B Dobbs Journal: Best Pract Res Clin Rheumatol Date: 2020-07-26 Impact factor: 4.098
Authors: Eve M D Smith; Sammy Ainsworth; Michael W Beresford; Veerle Buys; Wendy Costello; Yona Egert; Helen E Foster; Lovro Lamot; Berent J Prakken; Christiaan Scott; Simon R Stones Journal: Pediatr Rheumatol Online J Date: 2020-09-11 Impact factor: 3.054
Authors: Eve M D Smith; Sajida Rasul; Coziana Ciurtin; Eslam Al-Abadi; Kate Armon; Kathryn Bailey; Mary Brennan; Janet Gardner-Medwin; Kirsty Haslam; Daniel P Hawley; Steven Lane; Alice Leahy; Valentina Leone; Gulshan Malik; Devesh Mewar; Robert Moots; Clarissa Pilkington; Athimalaipet V Ramanan; Satyapal Rangaraj; Annie Ratcliffe; Phil Riley; Ethan Sen; Arani Sridhar; Nick Wilkinson; Michael W Beresford; Liza J McCann; Christian M Hedrich Journal: Rheumatology (Oxford) Date: 2021-11-03 Impact factor: 7.580